DNA Methylation Biomarkers in Cancer Diagnostics

Ivana Baranova; Marek Samec; Renata Pecova; Martin Pec; Zuzana Dankova

doi:10.2478/acm-2024-0001

Acta Medica Martiniana (Apr 2024)

DNA Methylation Biomarkers in Cancer Diagnostics

Ivana Baranova,
Marek Samec,
Renata Pecova,
Martin Pec,
Zuzana Dankova

Affiliations

Ivana Baranova: Department of Pathological Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia
Marek Samec: Department of Medical Biology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia
Renata Pecova: Department of Pathological Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia
Martin Pec: Department of Medical Biology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia
Zuzana Dankova: Biobank for Cancer and Rare Diseases, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia

DOI: https://doi.org/10.2478/acm-2024-0001
Journal volume & issue: Vol. 24, no. 1
pp. 1 – 6

Abstract

Read online

Cancer development and progression are characterized by intricate genetic and epigenetic alternations, with DNA methylation playing a crucial role in this transformative process. Recent advancements in DNA methylation mapping technologies have significantly contributed to the identification of novel cancer biomarkers. We provide a short overview of Conformité Européenne-marked in vitro diagnostic tests designed to detect DNA methylation changes in oncology practice.

Published in Acta Medica Martiniana

ISSN: 1335-8421 (Print); 1338-4139 (Online)
Publisher: Sciendo
Country of publisher: Poland
LCC subjects: Medicine
Website: https://sciendo.com/journal/ACM

About the journal

Abstract

Keywords